A new surgical approach for fertility-sparing management of diffuse endometrial G2 endometrioid adenocarcinoma: a step-by-step technique
| Autor: | U Catena, M Mirandola, F.M. Capomacchia, F Fanfani, G Scambia |
|---|---|
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Facts, Views and Vision in ObGyn. 15:79-81 |
| ISSN: | 2684-4230 2032-0418 |
| DOI: | 10.52054/fvvo.15.1.058 |
| Popis: | Background: 4% of endometrial cancers are diagnosed in young women and 70% are nulliparous. Preserve fertility in these patients is of major interest. It is demonstrated that hysteroscopic resection of focal well-differentiated endometrioid adenocarcinoma, followed by progestins achieve a complete response rate of 95.3%. Recently, fertility-sparing treatment was proposed also in case of moderately differentiated endometrioid tumors, with a relatively high remission rate. Objective: To show a new hysteroscopic approach, in case of fertility-sparing treatment of diffuse endometrial G2 endometrioid adenocarcinoma. Materials and Methods: Stepwise demonstration of the technique with narrated video footage for the fertility-sparing management of diffuse endometrial G2 endometrioid adenocarcinoma, combining the use of a 15 Fr bipolar miniresectoscope and ‘three-steps’ resection technique (Karl Storz, Tuttlingen, Germany) with a Tissue Removal Device (TRD) (Truclear Elite Mini, Medtronic). Main outcome measures: negative hysteroscopic assessment and endometrial biopsies at three and six months. Results: Normal endometrial cavity and negative biopsies Conclusion: Combined hysteroscopic technique, in case of diffuse endometrial G2 endometrioid adenocarcinoma, followed by double progestin therapy (Levonorgestrel releasing Intrauterine Device + Megestrole Acetate 160 mg/daily), may be associated with higher complete response rate; the use of TRD to complete the resection near tubal ostia may reduce risk of post-operative intrauterine adhesions and improve reproductive outcomes. What is new? A novel, fertility-sparing surgical approach for diffuse endometrial G2 endometroid adenocarcinoma. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|